Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - A comparative pilot study

BMC Ophthalmology

Volumn 11, Issue 1, 2011, Pages

  Norlaili, Mustapha ^a   Bakiah, Shaharuddin ^b   Zunaina, Embong ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HOSPITALIZATION; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; LASER COAGULATION; MALE; MIDDLE AGED; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; VISUAL ACUITY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TRIAMCINOLONE; VISUAL ACUITY;

EID: 81555237318     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-11-36     Document Type: Article

References (18)

1. Agreement of the Heidelberg Retina Tomograph II macula edema module with fundus biomicroscopy in diabetic maculopathy. Kisilevsky M, Hudson C, Flanagan JG, Nrusimhadevara RK, Guan K, Wong T, Mandelcorn M, Lam WC, Devenyi RG, Arch Ophthalmol 2006 124 3 337 342 10.1001/archopht.124.3.337 16534053
2. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Sutter FK, Simpson JM, Gillies MC, Ophthalmology 2004 111 11 2044 2049 10.1016/j.ophtha.2004.05. 025 15522370 (Pubitemid 39446723)
3. Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema. Ip MS, Diabetes Care 2004 27 7 1794 1797 10.2337/diacare.27.7.1794 15220269 (Pubitemid 38857466)
4. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr, Arch Ophthalmol 1992 110 8 1155 1159 10.1001/archopht.1992.01080200135041 1497531
5. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Ozkiris A, Evereklioglu C, Erkili K, Tamelik N, Mirza E, Eur J Ophthalmol 2004 14 6 543 549 15638105 (Pubitemid 40127969)
6. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema. Karacorlu M, Ozdemir H, Karacorlu S, Alacali N, Mudun B, Burumcek E, Eye 2005 19 4 382 386 10.1038/sj.eye.6701512 15309024 (Pubitemid 40553136)
7. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A, Ophthalmology 2004 111 2 218 245 10.1016/j.ophtha.2003.05.037 15019365 (Pubitemid 38183217)
8. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Jonas JB, Kreissig I, Sofker A, Degenring RF, Arch Ophthalmol 2003 121 1 57 61 12523885 (Pubitemid 36401766)
9. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Yanyali A, Nohutcu AF, Horozoglu F, Celik E, Am J Ophthalmol 2005 139 5 795 801 10.1016/j.ajo.2004.12.017 15860282 (Pubitemid 40614763)
10. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema. Dehghan MH, Ahmadieh H, Ramezani A, Entezari M, Anisian A, Int Ophthalmol 2008 28 1 7 17 10.1007/s10792-007-9097-y 17589809
11. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Wilkinson CP, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy Project Group, Ophthalmology 2003 110 9 1677 1682 10.1016/S0161-6420(03)00475-5 13129861 (Pubitemid 37025422)
12. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema. Batioglu F, Ozmert E, Parmak N, Celik S, Int Ophthalmol 2007 27 5 299 306 10.1007/s10792-007-9072-7 17453151 (Pubitemid 47377474)
13. Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six-month prospective longitudinal pilot study. Lam DSC, Chan CKM, Tang EWH, Li KKW, Fan DSP, Chan WM, Clin Experiment Ophthalmol 2004 32 6 569 572 10.1111/j.1442-9071.2004.00903.x 15575825 (Pubitemid 40074100)
14. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Larson J, Zhu M, Sutter F, Gillies MC, Am J Ophthalmol 2005 139 5 802 806 10.1016/j.ajo.2004.12. 054 15860283 (Pubitemid 40614764)
15. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema. Lee HY, Lee SY, Park JS, Korean J Ophthalmol 2009 23 3 153 158 10.3341/kjo.2009.23.3.153 19794940
16. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. Ozdemir H, Karacorlu M, Karacorlu SA, Am J Ophthalmol 2005 140 2 251.e1 251.e6 10.1016/j.ajo.2005.03.004 (Pubitemid 41125804)
17. Intravitreal triamcinolone for diffuse diabetic macular oedema. Gibran SK, Cullinane A, Jungkim S, Cleary PE, Eye 2006 20 6 720 724 10.1038/sj.eye.6701992 16021193 (Pubitemid 43880592)
18. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Lam DSC, Chan CKM, Mohamed S, Lai TYY, Lee VYM, Liu DTL, Li KKW, Li PSH, Shanmugam MP, Ophthalmology 2007 114 12 2162 2167 10.1016/j.ophtha.2007.02. 006 17459479 (Pubitemid 350181096)